Purdue researchers are developing and commercializing a targeted drug combination that once injected into a patient could speed up and improve bone fracture healing, and significantly cut recovery costs.
Novosteo Inc., a startup developing the technology, was co-founded by father and son team Philip Low, the Purdue Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry and Stewart Low, a postdoctoral staff member in Purdue’s Department of Chemistry.
Stewart Low said bone fractures can pose several risks to patients.
“People over 65 years of age who experience bone fractures, specifically hip fractures, have a one in four chance of dying from fracture-related complications. Half of these patients will not regain full mobility within a year,” he said. “We plan to focus initially on hip fractures in the elderly. We believe this is an area of underdevelopment and concern, so our goal is to help provide a better solution for these patients.”
Novosteo is developing fracture-targeted bone anabolic agents that selectively accumulate on the bone fracture surface where they accelerate the healing process.
“When we inject this drug systemically, it will circulate throughout the entire body but only accumulate at the fracture site,” Low said. “Because of this, we’re potentially able to bypass any side effects and give patients drugs that would otherwise be too potent to administer. Essentially, doctors will be able to give higher drug doses and have reduced patient side effects.”
Low said the drug’s targeted ability is what makes it superior to conventional options.
“The only clinically approved bone healing drug must be applied locally during surgery, where the pharmaceutical is painted directly onto the broken bone,” he said. “This is an invasive process, and one we’re trying to avoid. Our technology is similar to an insulin shot, an injection of the drug needed as the first line of defense.”
The technology could also have a large economic impact, Low added.
“Healing a bone fracture can cost over $80,000 from start to finish, including nursing home costs,” he said. “By helping patients to heal faster, we can reduce the nursing home and recovery costs significantly and users will be able to afford the small extra cost of our drug.”
Low said the drugs could be beneficial in several other applications.
“Our drug could be applied to any fracture and should be particularly beneficial to athletes or anyone who may be missing extended periods of work because of a bone fracture,” he said. “We might also be able to aid people who are not eligible for surgery, such as hip-replacement candidates and patients with other limitations. We’ve developed a drug that speeds up the osseointegration process, the formation of a direct interface between an implant and bone, so it could also help these procedures and significantly decrease recovery time.”
A video about the technology can be viewed by clicking here. The company is a member of the Purdue Startup Class of 2017.
Technology used by Novosteo is licensed through the Purdue Research Foundation Office of Technology Commercialization.
Novosteo is currently in the preclinical stage of drug testing and is seeking funding to continue development.
“Through preclinical studies we have demonstrated that our drug heals bone fractures better than an untargeted drug,” Low said. “We’ve shown that we can dramatically speed up and improve the fracture healing process. With further funding we hope to make more strides in proving the efficacy of the drug and accelerating its translation into the clinic.”
The Latest on: Bone fracture healing
via Google News
The Latest on: Bone fracture healing
- Where are they now?: Amos' love for teammates beats stronger with new hearton June 25, 2020 at 6:06 pm
She had an untimely collar bone fracture before her freshman season and then thought ... They set a goal of raising an estimate of the money Amos would need during the recovery process and then saw ...
- BBS-Bioactive Bone Substitutes Plc: Managers' Transactionson June 25, 2020 at 11:35 am
Pekka JalovaaraPosition: Member of the Board/Deputy member(X) Legal personIssuer: BBS-Bioactive Bone Substitutes OYJLEI:.
- BBS-Bioactive Bone Substitutes Plc: Final results of the successful rights issue - oversubscribed by 49 percenton June 24, 2020 at 6:54 am
According to the final results of the rights issue (“the Share Issue”) of BBS-Bioactive Bone Substitutes Plc (“BBS” or “the Company”) that ended on 16 June 2020 in Sweden and on 18 June 2020 in ...
- Bioactive factors-imprinted scaffold vehicles for boosting bone repairon June 23, 2020 at 7:42 pm
Announcing a new article publication for BIO Integration journal. In this review article the authors Peng-Peng Xue, Jian-dong Yuan, Qing Yao, Ying-Zheng Zhao and He-Lin Xu, from Wenzhou Medical ...
- Seahawks’ rookie TE Colby Parkinson has surgery for broken bone in foot, likely out 4 monthson June 19, 2020 at 3:50 pm
Rookie tight end Colby Parkinson, the Seattle’s fourth-round choice in April’s draft, broke the bone along the outside of his foot while training this month, according to NFL Network’s Ian Rapoport.
- Richie Jones broke a bone in his wriston June 19, 2020 at 8:29 am
The 49ers have multiple injuries to deal with at wide receiver heading into training camp. Word of Deebo Samuel‘s broken foot came on Thursday and Friday’s news concerns Richie James. Mike Garafolo of ...
- Scientists develop a biodegradable alloy for bone implants for fractures, osteoporosis and myelomaon June 19, 2020 at 7:18 am
Material scientists from NUST MISIS and the University of Western Australia have presented an innovative bioresorbable alloy based on magnesium, gallium and zinc. The material can be used for the ...
- Study shows nervous and immune systems 'need to talk' for bone repairon June 19, 2020 at 6:18 am
In a December 2019 study, a team of Johns Hopkins Medicine researchers demonstrated in mice that repair of bone fractures requires the generation, growth and spread of nerve cells, or neurons, ...
- Lewis Gale rolls out new Fracture Liaison programon June 18, 2020 at 3:11 pm
So Lewis Gale has been working on a Fracture Liaison program that’s unique to them for Southwest Virginia, targeting preventive care, especially for folks who have already sustained fractures. The ...
- Primitive stem cells point to new bone grafts for stubborn-to-heal fractureson June 16, 2020 at 1:23 pm
Although most broken bones can be mended with a firm cast and a generous measure of tender loving care, more complicated fractures require treatments like bone grafting. Researchers at Texas A&M ...
via Bing News